Global Morpho Pharma

About Global Morpho Pharma

Global Morpho Pharma operates in the Other / Uncategorized space and is among the firms Bracken expects to track at SNMMI 2026.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

What we're seeing

• Nuclear Medicine Today · 2026-03-02
  Global Morpho Pharma files IND for next-generation PSMA-targeted agent
  Coverage notes the company's growing footprint in the radioligand therapy space.
• PR Newswire · 2026-04-25
  Global Morpho Pharma partners with academic center on Actinium-225 program
  Coverage notes the company's growing footprint in the radioligand therapy space.
• Imaging Wire · 2026-09-16
  Global Morpho Pharma closes Series C round to scale radiopharma manufacturing
  The work builds on more than a decade of radiochemistry collaboration.
• STAT News · 2026-02-23
  Global Morpho Pharma publishes dosimetry data at SNMMI 2026
  Industry observers expect more activity of this kind in the run-up to SNMMI 2026.

Mocked while we wire the Exa integration. Headlines are illustrative.

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.